Taysha Gene Therapies
TSHA
NZ$4.40
Share price
-1.87%
Change (1 day)
13.30%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total assets
Total assets on the balance sheet as of March 2025 : NZ$0.23 Billion
According to Taysha Gene Therapies's latest financial reports the company's total assets are NZ$0.23 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taysha Gene Therapies - Total assets on balance sheet (from 2020 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | NZ$0.28 B | 4.1% |
| 2023-12-31 | NZ$0.27 B | 37.33% |
| 2022-12-31 | NZ$0.19 B | -36.51% |
| 2021-12-31 | NZ$0.31 B | -12.7% |
| 2020-12-31 | NZ$0.35 B | 1610812.4% |
| 2019-12-31 | NZ$0.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$0.40 B | 75.52% | 🇺🇸 USA |